___
Svenska
Career
Contact
Facebook
Twitter
Linkedin
About IRLAB
About IRLAB
Management
Board of directors
Therapeutic focus
Therapeutic focus
Parkinson’s disease
Patient portrait
PD-LIDs
PD-Falls
Project portfolio
Project portfolio
Mesdopetam (IRL790)
Pirepemat (IRL752)
IRL942
IRL757
IRL1117
Discovery phase
Research platform
ISP platform
Scientific publications
Newsroom
Newsroom
Press releases
Event calendar
Image library
Investors
Investors
Capital Markets Day 2023
Financial reports
Presentations & events
The share
Owners
Share capital development
PDMR transactions
Analysts
Financial calendar
CMD 2022
Listing Nasdaq Stockholm Main Market 2020
Rights issue Feb 2020
Initial public offering 2017
IR contacts
Corporate Governance
Corporate Governance
General Meetings
Annual General Meeting 2024
Previous general meetings
Corporate governance reports
Nomination committee
Nomination Committee for the AGM 2024
Previous nomination committees
Auditor
Remuneration
Internal control
Diversity
Articles of association
Nicholas Waters, EVP, Head of R&D, presents at the ABGSC Investor Day
March 8, 2023
Nicholas Waters, EVP, Head of R&D, presents the company at the ABGSC Investor Day on March 8, 2023.